Global Macrolide Antibiotics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drug;

Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin.

Segmented by Route Of Administration;

Infection Due To Mycoplasma Pneumonia, Legionella Sp, Or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections and Others.

Segmented by End User;

Hospitals, Dermatology Clinics, Pharmaceutical Companies and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn659664674 Published Date: April, 2024 Updated Date: May, 2024

Introduction

Global Macrolide Antibiotics Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 91.3
2021 101.5
2022 108.0
2023 120.9
2024 141.7
2025 149.6
2026 152.5
2027 175.8
2028 195.6
2029 206.4
2030 209.1

In the year 2023, the Global Macrolide Antibiotics Market was valued at USD 56,087.30 million. The size of this market is expected to increase to USD 129,574.86 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 12.7%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug
    2. Market Snapshot, By Route Of Administration
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Macrolide Antibiotics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Macrolide Antibiotics Market, By Drug, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Azithromycin
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Clarithromycin
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Erythromycin
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Fidaxomicin
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Telithromycin
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Macrolide Antibiotics Market, By Route Of Administration, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Infection Due To Mycoplasma Pneumonia, Legionella Sp, Or Bordetella Pertussis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Symptomatic Cat-Scratch Disease
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Bacillary Angiomatosis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Peliosis Hepatis In Patients With AIDS
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Cerebral Toxoplasmosis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Uncomplicated Skin Infections
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        7. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Macrolide Antibiotics Market, By End User, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Hospitals
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Dermatology Clinics
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Pharmaceutical Companies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    4. Global Macrolide Antibiotics Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020 - 2030 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Merck Sharp & Dohme Corp
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Teva Pharmaceutical Industries Ltd.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Fresenius Kabi USA
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Sandoz International GmbH
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Macrolide Pharmaceuticals
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Neo Química
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Male Infertility
Global Male Infertility Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Male Infertility Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Maggot Debridement
Global Maggot Debridement Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Maggot Debridement Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare In Vitro Diagnostics Magnetic Resonance Imaging
Global Magnetic Resonance Imaging Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Magnetic Resonance Imaging Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Malabsorption Syndrome
Global Malabsorption Syndrome Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Malabsorption Syndrome Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...